Fundraising, Venture Capitalists, Angel Investors in Healthcare 3D Printing (Premium)

One of the most exciting missions at 3DHEALS is discovering early-stage startups, meeting the founders, and helping these companies with fundraising through our Pitch3D program. Our goal is to save the founders and selected institutional investors time to meet each other at the right time along the company’s journey at zero cost to either side. Since April 20th, 2018, 3DHEALS has hosted numerous online and offline Pitch3D sessions regularly, introducing 30+ startups from all over the world to institutional investors who are interested in healthcare 3D printing, bioprinting, and adjacent fields including AI and cybersecurity (within 3D printing), 3D scanning, VR/AR, 3D Visualization, synthetic materials, and regenerative medicine. In this unique 3DHEALS virtual event, we would like you to meet some of the VCs and angel investors behind the scene and learn more about the medical device and biotechnology investment environment under the current macroeconomy. The format of this event will focus on a moderated panel discussion focusing on the current status, short-term, and longer-term outlook of the institutional investment landscape. The audience is welcome to bring many questions to this rare and unique opportunity and engage live.


Tak Cheung

Tak joined NEA in 2018 and is currently a Partner on the healthcare team. He focuses on medical device investments.

Prior to NEA, Tak was a Venture Partner at Merieux Development Venture Fund where he led all phases of investment for healthcare startups, including sourcing, diligence and investment approvals. Tak also co-founded Lexington Medical, a commercial-stage medical device startup in the gastrointestinal surgery space. Prior to Merieux and Lexington, Tak was VP of Business Development for the Global Surgical Division at Bausch & Lomb, and was responsible for all business development efforts in the ophthalmic surgical division. Tak has held various corporate and business development leadership roles at Edwards Lifesciences in the Heart Valve Therapy Division and Advanced Medical Optics (acquired by Johnson & Johnson).

Tak received a BS with Honors in Engineering and Applied Science from the California Institute of Technology, an MD from the University of California, Irvine, and an MBA from Harvard Business School.

Tom Gwinn

Tom Gwinn is an Investment Manager at Evonik Venture Capital (EVC) based in Silicon Valley. Tom has been actively involved in the technology community in the valley for over a decade. Prior to joining Evonik, Tom has held roles in venture capital investing, startup patent strategy, and applied physics research — providing a broad set of experiences to draw upon in support of Evonik’s investments. Tom has a B.S. in Electrical Engineering from Caltech, an M.S. in Electrical Engineering from Stanford, and a J.D. from Stanford Law School.

Tom Vogelsong

Tom is an angel investor in MedTech and a Life Science Advisor to and Director of Deal Flow for Kyto Technology and Life Science ( Tom is also an advisor to Medtech Innovator, Silicon Valley Advantage, US Angels, Edge AI and Embedded Vision Alliance, Camdo, InQCel, and Lehigh University’s new College of Health. He received his PhD in Electrical Engineering and has a background in technology, entrepreneurship, medical devices, and biochemistry. Tom scouts early-stage investment opportunities for Kyto in MedTech, BioTech, Diagnostics, and Tech. He has executive experience along with technical expertise and business development background with startups, including as CEO of venture-backed Photon Vision Systems, as well as with medium and large size companies including GE Medical. Tom has invested in startups and helped companies raise capital as well as coaching them to set a vision for growth and making connections for them to achieve success. Tom invests in MedTech and Tech directly as an angel investor and as part of Kyto.

Natalie Levy

Natalie Levy is the Founder of She’s Independent, a women-first investment group offering an entirely new way to support women’s financial independence and influence through investing and board placements. As a member-led investment group, She’s Independent marries empowerment and action, with the ultimate mission of closing the power gap in investing by getting more women on the cap table, in the boardroom, and into positions of influence. Over the next 12 months, She’s Independent plans to deploy $1.5M of capital collectively, and has invested in 9 deals since its formation in January 2022. An accomplished engineer turned Wall Street derivatives trader, investor, and advisor, Natalie has over a decade of tech operational experience, a portfolio of 30+ seed through later stage private investments, and has experienced liquidity events across 3 of the first 4 investments in her growth technology portfolio with an average return >20X. Natalie resides in Boulder, CO with her loving rescue pup Beans and is passionate about gender equity and mental health awareness.

Jimmy Lu

Jimmy is a Co-Founder & Managing Director of Eos BioInnovation, a new venture that incubates projects and invests in early-stage startups in the Regenerative Medicine field originating from top academic and research institutions.  

Prior to Eos, Jimmy was a Managing Director/Senior Partner in the San Francisco office of WI Harper, bringing over 25+ years of technology/healthcare and venture capital experience. While at WI Harper, he had been the leader of the healthcare team investing in the medical device, healthcare services and biotech/life science sectors. Jimmy was a Board Director of DeepBiome Therapeutics, Panorama Medicine, Kindstar Globalgene Technology, China Diagnostics Medical Corporation (Chemclin), StemCyte Inc., and Circle Pharma.

Before joining WI Harper, Jimmy co-founded and was a General Partner of iD Ventures (Acer Technology Ventures), with key investments that included iRobot Corporation, Harmonix Music, Monolithic Power Systems, and Fortinet.

Jimmy earned a BA from Yale College, an MBA from Harvard Business School and a JD from UC Berkeley School of Law. He serves on the University of Florida College of Engineering West Coast Advisory Board, and he is a member of the advisory board of Elm Street Ventures and is Co-Chair of the Investment Committee for the National Foundation for Cancer Research AIM-HI Accelerator Fund (Women’s Venture Competition).

Arno Held

Arno Held is Managing Partner of AM Ventures and specializes on the firm‘s ecosystem, as well as its global footprint and organizational growth. He started AM Ventures together with Johann Oberhofer in 2014. In total, Arno has more than 23 years of experience in industrial laser and manufacturing technologies and spent more than half of this time in the world of industrial 3D printing. 

Since founding AM Ventures, Arno has been instrumental in building the AM Ventures team that has scouted more than 2,500 3D printing startups all over the world, conducted more than 35 rounds, built a €100m VC fund and today holds a portfolio of 17+ shareholdings in 6 countries on 3 continents. 

Arno holds a diploma degree in industrial engineering and management from the University of Applied Sciences Karlsruhe (Germany) as well as an international executive MBA from the University of St. Gallen (Switzerland). Arno completed his studies in Shanghai, China and Cape Town, South Africa.


Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.

3DHEALS Los Angeles: Discovering Healthcare 3D Printing

Live recording of past event in Los Angeles, September 26th, 2018.

Live Event Agenda:

7:00-7:10 PM Dr.  Jenny Chen  (3DHEALS)
7:10-7:15  PM Q & A
7:15-7:25 PM Mr. Steven Morris (BIOLIFE4D)
7:25-7:30 PM Q &A
7:30-7: 40 PM Dr. Sanjay Sinha (UCLA)
7:40- 7:45 PM Q & A
7:45-7:55  PM Dr. Ali Khademhosseini (UCLA)
7:55-8:00 PM Q&A
8:00-8: 10 PM Dr. August de Oliveira
8:10-8:15 PM Q&A
8:15-8:45 PM Panel Q&A

Mr. Steven Morris 

BIOLIFE4D Founder and CEO Steven Morris possess more than 20 years of extensive experience in precision manufacturing, including 15 years serving as President of privately-held Inland Midwest Corporation (IMC) where he led the company’s transformation into a premier, state-of-the-art facility catering exclusively to the medical technologies industry. After several years of high profitability, Steven negotiated a successful exit strategy and sold the company in 2011.  After remaining on as President for over two years, he left and started BIOLIFE4D, an emerging biotech company working on the technology to bioengineer a human heart viable for transplantation using a patient’s own cells. His diverse and comprehensive knowledge of medical devices, processes optimization, and medical technologies will be extremely beneficial to the success of BIOLIFE4D.

Dr. Ali Khademhosseini

Levi Knight Chair. Professor of Bioengineering, Chemical Engineering, and Radiology at UCLA, Previously @Harvard and @MIT for 16 years, biomedical researcher, innovator, mentor, world traveler, educator, ACS Nano Assoc. Editor

Dr. Sanjay Sinha

Dr. Sanjay Sinha is an Interventional Pediatric Cardiologist and Assistant Professor of Pediatrics at UC Irvine and UCLA Mattel Children’s Hospital. He completed his medical school at the University of Arizona college of medicine and then moved to Los Angeles for his training. He completed his pediatric residency, pediatric cardiology fellowship, and extra interventional procedural training at UCLA Mattel Children’s hospital. His research interests are in transcatheter valve replacement in congenital heart disease. He has worked extensively in the area of 3D modeling for both surgical and interventional procedural planning and is currently the co-founder of the Congenital and Structural 3D Printing Program at UCLA.

Dr. August De Oliveira

Dr. August De Oliveira graduated in the top 10% of his class at the University of Washington School of Dentistry in 1997. After moving to Los Angeles from Seattle, Dr. de Oliveira did an optional additional year in a General Practice Residency at the VA Sepulveda where he learned advanced techniques in Endodontics (Root Canals), Dental Implants, and Restorative Dentistry. Dr. de Oliveira lectures weekly all over the nation on three subjects: CAD/CAM (same day crowns), CBCT (3D x-rays), and dental implants. On implants, he lectures from the basics of single-tooth implants to advanced Edentulous (no teeth) treatment. He has been published in many peer-reviewed journals and is widely recognized as a pioneer in CBCT Guided Surgery. Dr. de Oliveira has developed software for numerous dental companies and has authored two textbooks on dental implants.

Healthcare 3D Printing Ecosystem: India (Premium)

In this lightning round, we would like to connect experts from the Indian healthcare 3D printing ecosystem with 3DHEALS audiences around the world, highlighting their breakthroughs, and entrepreneurial lives, and opening new conversation channels on partnerships. We have curated a group of highly diverse and representative panelists from dental 3D printing, medical 3D printing, and bioprinting space. While it is impossible to really dive deep into the entrepreneurial culture and ecosystem of the community without actually physically being there, we aim to bring the most influential voices to the virtual event to give everyone a taste of what it is like to invest in, work for, and partner with Indian startups in the space.


Mahesh Kappanayil

Dr.Mahesh Kappanayil is a Professor of Pediatric Cardiology at Amrita Institute of Medical Sciences and Research Center, Kochi, Kerala, India. He is also the founder and lead of the 3D Printing, Virtual Reality and Innovation Laboratory at Amrita. As a pediatric cardiologist, he has been involved with various facets of the field including high-end transcatheter interventions, advanced cardiac imaging and clinical research. He helped establish India’s first dedicated cardiac MRI program for congenital heart diseases at Amrita. He has been involved in exploring the application of 3D+ technologies in Healthcare for well over a decade. In 2015-16 he helped establish the region’s first “Point-of-Care” medical 3D printing Lab at Amrita, and in 2020-21 expanded the scope of the lab to Extended Reality applications for medicine. These Labs today are hub of multi-disciplinary innovations in leveraging 3D+ technologies for healthcare applications. He believes that technology is a great equaliser, and cutting-edge technologies of 3D Printing and Extended Reality are set to revoutionalise medicine and healthcare in a big way, even in limited resource environments. Dr.Mahesh has won several national awards and recognitions for his work in this area, and has numerous expert lectures and publications to his credit.

Piyush Padmanabhan

Piyush’s journey into the world of Bioprinting began with his experience in the organ transplantation sector. Post his under graduation from Vellore Institute of Technology, Piyush began his career in the pharmaceutical sector at Biocon Limited and then at Roche Pharmaceuticals, where he worked closely with physicians and transplant coordinators in Kidney and Liver Transplants. The ever-widening gap in organs available for transplant and the need for these organs was very apparent to him. This led him to begin Next Big Innovation Labs® with Alok and Pooja, the other two co-founders of the company. In his role as the CEO and Co-Founder of Next Big Innovation Labs®, Piyush has led various deep technology projects in bioprinting and has also played a pivotal role in raising central and state government funding for the company. Some of the projects he has led are the following: the development of India’s first customized 3D Bioprinter, the development of unique temperature control fixtures for diverse bioprinting components and AI/ML integration into Trivima Bioprinting Systems. Piyush currently holds two technology patents and one process patent in the domain of bioprinting and considers himself to be an eternal student. His goal is to one day bridge the gap in the organ transplantation sector and believes in deep collaborations to achieve this goal.

Mahesh Dhoka 

I have done post my bachelors, taxation, and law along with business management. later joined family business where we are making high purity iron powders and flakes for food, pharma, aerospace and engineering industries exporting to about 30 countries across the world. started 3D Incredible in 2017 with an idea to bring this technology to the masses in India specially with respect to medical applications. so far we have done close to 1400 implants across more than 30 cities in India working and promoting 3d printing with close to 700 surgeons. with respect to engineering, we work with companies across various sectors right from prototyping to small batch production.

Yearla Srinivasa Rao

Yearla Srinivasa Rao is presently working as a chief operating officer of Medoja Health Private Limited, which is a healthcare company with a focus on 3D printing of patient-specific bespoke customized implants using novel biomaterials, and manufacturing of biomaterials from natural sources for medical 3D printing applications. Bone defects are filled with ceramic granules traditionally in many cases, without considering the shape fidelity to the defect or providing vascular supply. Medoja addressed this by using a ceramic composition which can be 3D printable to address shape fidelity and generate vascular supply to it. Yearla completed his Ph.D. from the University of Hyderabad and has overall 6+ years of post PhD industrial experience in nanomaterials and biomaterials based product development for agriculture, cosmetic, nutraceuticals, and pharmaceutical industries. He managed project activities from BIRAC and DBT during his tenure in the industry along with working in a multidisciplinary environment to manage sales, marketing, production, and business development, teams.

Dr. Jatin Kakrani

Co-Founder – 

Certified Dental Implant & Digital dentistry trainer 

DCI accredited speaker 

Gold Medalist Prosthodontist |


Firoza Kothari

Firoza Kothari, Co-Founder & CTO – Anatomiz3D Medtech Pvt. Ltd. – A B.Tech in Biotechnology Engineering and now Forbes 30 under 30 – Asia – Healthcare and Science, 2020, Firoza Kothari started her journey to provide patient-specific medical solutions and one day end the organ donation problem by creating live organs out of patients’ stem cells. With that aspiration, she gave birth to Anatomiz3D, a startup focusing on medical 3D printing. She, along with her team, was the first to execute soft tissue models in India through Paediatric Cardiology, partial amputee prosthetic hand, the first kidney tumor case in India, and the model for tongue cancer was the first in the world. Being a Co-founder and CTO of Anatomiz3D, she, along with her team, has successfully added 2000 plus case studies. Her multi-disciplinary expertise prevails in converting 2D DICOM CT/MRI/Echo Scans to 3D Printed anatomical replicas, medical devices, and allied products, using various combinations of Hardware and Software, across multiple medical specializations. Anatomiz3D has played a vital role in creating the market for 3D Printing in the Medical industry in India since 2015 and is a pioneer for the same, also being the first in India to enable Hospital-Industry partnerships for Point-of-Care Labs.

3DHEALS Startup Showcase: Singapore (Premium)

3DHEALS is returning to Singapore once again to co-host an exciting start-up showcase event with NAMIC to connect local business leaders, innovation enthusiasts, investors, and entrepreneurs in the healthcare 3D printing, bioprinting, and medical technologies space. This showcase event is a premier opportunity to hear directly from founding team members to learn more about the thriving Singaporean start-up ecosystem as they strive towards shaping the future of patient care. In the lead up to the event, gain a deeper understanding of the contributing factors to Singapore’s start-up success through our in-depth guide found here.


Ben Holmes

CEO and Co-Founder of Nanochon

Dr. Ben Holmes is an entrepreneur, medtech executive, inventor and scientist. He is the founder of Nanochon, which is commercializing a 3D printed implant for regenerating lost or damaged cartilage in joints. His academic background is in 3D printing and biomaterials for tissue engineering and regeneration.

Adam Jakus

Co-Founder and Chief Technology Officer of Dimension Inx


Dr. Adam Jakus is Co-Founder and Chief Technology Officer of Dimension Inx, a Chicago-based, advanced biomaterials and biofabrication company. As CTO, Adam leads Dimension Inx internal innovation, external collaborative projects, as well as manufacturing activities. For the past 11 years, Adam has been intimately involved with advanced, functional material design for 3D-printing and bioprinting, covering and developing new 3D-printable materials as diverse as metals and alloys, ceramics, graphene and nanotubes, extraterrestrial regoliths, gels, and advanced hard and soft tissue regenerative biomaterials – encompassing a materials-centric platform now collectively referred to 3D-Painting. With a Ph.D. in Materials Science and Engineering from Northwestern University and B.S. and M.S. degrees in Materials Science and Engineering from Georgia Tech, Adam is a Materials Engineer at heart and believes the future of medical and non-medical technologies lies in the development of new, advanced materials.

Chia Lye Peng

Co-Founder and CEO of FlexoSense

Lye Peng has more than 25 years of multi-faceted Asia Pacific and global experiences in the MNC and SME environment; including technology licensing, business development, sales and marketing, e-commerce, learning & development and operations. Her intrapreneurial & enterprising skills have had provided opportunities in ground-breaking stretch goals initiatives, in collaboration with global colleagues across diverse cultures, perspectives and domain expertise. She brings these experiences and skillsets to FlexoSense as a co-founder & CEO where she hopes the Singapore-based company can create a global impact under UN Sustainable Development Goal (SDG) #3, Good Health and Well-Being. Encouraging a growth mindset, she is ever ready to champion bold ideas from colleagues that dovetail with this SDG #3. Having a family history of diabetes, the first area of impact the company hopes to make a difference is in the global diabetes problem.

Amrish Nair

Co-Founder and CEO of Biorithm

Born and raised in Singapore, Amrish Nair received his B.Eng. and M.Eng. from the School of Electrical and Electronic Engineering at the Nanyang Technological University. His graduate studies research led him to numerous international publications and a US Patent on ECG signal analysis and monitoring. His research collaboration with TTSH cardiologist, Dr. David FOO and NTU supervisor Assoc. Prof. Pina Marziliano led him to spin-off BIORITHM, a medtech startup providing cutting-edge signal processing solutions in the fields of remote monitoring and wearable technology. Amrish Nair is passionate in developing medical device technologies for the well-being and health of patients. As one of the founding members of BIORITHM, Amrish and his team set out with the aim of making medical technology more affordable and available whilst pushing technological limits to greater progression.

Dr. Wei Jiang GOH

Co-Founder & Chief Executive Officer of Craft Health Pte Ltd

Dr Wei Jiang GOH is currently the Co-Founder & Chief Executive Officer of Craft Health Pte Ltd, where he oversees business development and investor relations, helming the company through its fundraising rounds. Previously a National University of Singapore (NUS) Graduate School of Integrative Sciences & Engineering (NGS) PhD-MBA scholar where he earned his PhD and MBA with specialization in Finance, his research interests include formulation science and Bio-Nanotechnology. He has published more than 10 peer reviewed research articles and hold several patents. Prior to that, Wei Jiang graduated from NUS Pharmacy in 2012 and practiced as a registered pharmacist.

Prof. Huang Dejian

Co-Founder of Kosmode Health Singapore Pte Ltd

Dejian was trained as a chemist with a PhD degree (1999) in inorganic chemistry from Indiana University and postdoctoral research experience (Chem Eng) from Massachusetts Institute of Technology. He began his independent research career in 2001 by venturing into the chemistry of food bioactive constituents for health promotion and disease prevention and plant proteins. Specifically: 

  • Chemistry of bioactive compounds in fruits and vegetables for controlling diabetes, anti-aging, antioxidants, anti-inflammation, anti-obesity 
  • Plant proteins for 3D printing of seafood mimics and scaffolds for cell-based meat culture and biomedical applications 

He has published over ~200 papers and was named by Thomson Reuters as a Highly Cited Researcher 2014 and 2015. Dejian is an associate editor of Journal of Functional Foods, and Frontiers in Nutrition Food Chem. He is a co-founder of Kosmode Health Singapore Pte Ltd (2016) (

Mike Graffeo

CEO and Co-Founder of Fluidform 3D

In over 20 years in the life sciences, Mike has brought four novel products through the FDA that have generated over $20 billion in sales in both startup and growth organizations. Throughout his career, he has worked on the forefront of medical technologies, translating highly complex products and clinical data into successful businesses, both in the US and around the world.

Timothy Chua

Digital Transformation Strategy and Biz Dev, HP Inc.

“I am an amicable young multipotentialite who is eager to learn about everything and hence I always ask many questions. I have a strong desire to contribute towards Singapore’s transition from a linear economy to a circular one and truly believe that this is possible here through a combination of design, reverse logistics and regulation. I envision myself gaining industry experience in my early career before moving onto consultancy work, followed by policy making and finally educating the next generation in my late years.”

Dr. Ho Chaw Sing

Managing Director of NAMIC

Dr Ho Chaw Sing is the co-founder Managing Director of NAMIC (National Additive Manufacturing Innovation Cluster), a Singapore government platform initiative to catalyse innovation and scale industrial adoption of digital additive manufacturing technologies. Since its inception in 2015, NAMIC has raised millions in public-private funding to catalyse various AM initiatives across several industry sectors. Before joining the public sector, he spent several years with HP Singapore and Chartered Semiconductor, where he undertook various executive roles in technology and product development, as well as supply chain and business operations. A technology-for-good advocate, Chaw Sing has been active in scouting and nurturing AM deep tech start-ups, contributing to the growing startup ecosystem in Singapore. Chaw Sing is the co-chair of the Singapore Standards AM Technical Committee, and sits in the ASTM International AM Centre of Excellence (AM CoE) Steering Committee. Chaw Sing earned his doctorate (Ph.D) in Electrical and Computer Engineering and Bachelor’s (honours) degree in Electrical Engineering with a major in Microelectronics from the National University of Singapore, where he is currently an adjunct Professor.


Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS. Her main interests include medical education, 3D printing in the healthcare sector, and artificial intelligence. She is also a current adjunct clinical faculty in the radiology department at Stanford Healthcare.

Mahendran V. Reddy

Mahendran Reddy

Mahendran Reddy is a highly driven professional with 20 years of international professional experience in the creative industries in both the private and public sectors.

As a trained architect and a media personality, he has held key strategic appointments in driving innovation and initiatives in the civil service, notably the establishment of the National Design Centre in Singapore.

At UCT, he has driven the adoption of Additive Manufacturing in its fledgling form in South East Asia mainly in the consumer segment of the business.

At NAMIC, he is actively involved in the adoption of Additive Manufacturing in the Industries by initiating collaborative research projects with Industry and Institutes of Higher Learning.

He brings with him an in-depth knowledge in management, government processes and procurement, design thinking skills and excellent interpersonal and professional competencies.

3DHeals Melbourne – 3D MedTech Innovation (Premium)

3DHeals Melbourne is returning in 2021 to highlight local collaborative innovations in health care 3D technologies and to provide a virtual platform to foster crosstalk between clinicians, academia, and industry. The focus for this event will be on the real-world applications of biomedical engineering as we will hear from leading experts in the fields of 3D printing, 3D modeling/digital design, medical devices, and implants, followed by a discussion panel to breakdown similar challenges that lie ahead and how best to synergize research and development efforts moving forward. 

3DHeals Melbourne welcomes all who are interested to learn more of the latest developments, practical applications, and future explorations of these exciting 3D medical technologies and how they can help shape the future of patient care.

Speaker info:

William Harley

William Harley

William Harley graduated with honors in medical biotechnology from the University of New South Wales. Currently, he is undertaking a Ph.D. at the University of Melbourne in acoustophoretic bioprinting. Stemming from his research experience in biomaterials, stem cells, and nanofabrication, he is driven by the clinical translation of personalized regenerative medicine. He is passionate about the innovation of 3D printing in healthcare and is determined to orchestrate a series of 3D HEALS events to engage in the Australian community.

Mark Roe

Managing Director of Fusetec

Mark Roe

Mark Roe, along with his business partner John Budgen founded Fusetec in April 2017, the business had a somewhat unconventional beginning. “When I was introduced to advanced manufacturing, the theory behind Industry 4.0 was compelling. I could really see a future in it,” said Roe. Once back in Australia, Mark considered the three major manufacturing industries in South Australia: aerospace, defense, and medical. He quickly landed on medical. “By opting to work in the medical industry, we could develop our own IP, with global applications.” It was then that he started canvassing medical professionals and academia to pinpoint that all-elusive problem to solve. The three most commonly cited issues were a lack of cutting guides, medical implants, and patient-specific models. However, he was not keen to pursue a business model based on personalized manufacturing. Mark leads the management team and passionately drives our Research & Development team, collaborating with Universities, Medical professionals, and Government entities worldwide.

Prof. Peter Lee

Professor in the Department of Mechanical Engineering at University of Melbourne/Director of ARC CMIT

Prof. Peter Lee obtained his BEng in Mechanical Engineering (1st Class Hons. 1991) and PhD (1996) in Bioengineering from the University of Strathclyde, UK, and continued his post-doc in the same university from 1996–1998.

Professor Peter Lee is the Director of the Australian Research Council (ARC) Training Centre for Medical Implant Technologies and the Chief Investigator in the ARC Training Centre for Personalised Therapeutic Technologies. As Director of the ARC Training Centre for Medical Implant Technologies, he leads the largest industry-university-hospital partnership in Australia focusing on orthopaedic and maxillofacial implants to train a new generation of interdisciplinary engineers in biomechanics, materials and manufacturing for the orthopaedic and maxillofacial implant industry. He joined the University of Melbourne, Australia, as a Senior Lecturer in 2008, and was promoted to an Associate Professor in 2011 and a Professor in 2015. Since then he has held several leadership positions including Deputy Head and Acting Head of Department of Mechanical Engineering, and currently as the Deputy Head (Research) of Department of Biomedical Engineering and leads the Cell and Tissue Biomechanics Laboratory in Engineering, where his research aims to better understand the behaviour of biological cells and tissues under mechanical forces. He has authored more than 140 publications in journals, conference proceedings and books. He is a regular reviewer for journals and grant bodies and currently the Deputy Editor for Journal of Orthopaedic Surgery and Research (Springer Nature), and Associate Editor for Frontiers in Pharmacology (Translational Pharmacology).

A/Prof. Kate Fox

Associate Dean of Higher Degrees by Research/ and Associate Professor within the School of Electrical and Biomedical Engineering at RMIT

Kate Fox is an Associate Professor in the School of Electrical and Biomedical Engineering. Kate is a biomedical engineer with significant experience and expertise in coatings and implant fabrication for orthopedic applications. Prior to joining RMIT, she was part of the Bionic Eye Project working to develop a high acuity diamond electrode capable of electrically stimulating retinal tissue. She is a reformed patent attorney and can advise on the patentability of research. Kate is committed to the real-world application of biomedical engineering and was shortlisted for the AFR 2018 Emerging Leader in Higher Education Award. Kate is experienced in working in highly complex, transdisciplinary projects, coordinating research teams, and providing the surgical integration necessary to transition an engineered product into a surgically feasible product. She has successfully attained over A$6M direct and in-kind funding. Kate is CI in the ARC ITTC in Additive Biomanufacturing and a 2019-2020 Superstar of STEM.

Dr. Lindsay Bussau BSc (Hons), PhD

Applications and Customer Support Manager, Optiscan Pty Ltd

The talk will discuss endomicroscopy and the basics of Optiscan’s handheld fibre-optic confocal microscope. Dr. Bussau will demonstrate the Optiscan FIVE2 (Viewnvivo) handheld confocal imaging system and will discuss the potential for use of confocal endomicroscopy to image tissue structure in vivo. Dr Bussau did his post-doctorate research on confocal laser fiber optic imaging and has 25 years of experience with the technology.

Dr. Yunlong Tang

Joint lecturer in the Department of Mechanical and Aerospace Engineering and the Department of Materials Science and Engineering Monash University

Dr. Yunlong Tang joined the Faculty of Engineering at Monash University in Feb 2020. Currently, he is a lecturer jointly appointed by the Department of Mechanical and Aerospace Engineering and the Department of Materials Science and Engineering.  His major research interests are in the general field of design and manufacturing, including smart manufacturing, additive manufacturing, and its related design methods, sustainable design and manufacturing, AI-aided design, CAD/CAM, design and fabrication of lattice or cellular materials. Yunlong has over nine years of international R&D experience, participating in several national research and industrial projects from China, Canada, Europe, and Singapore. He obtained his Ph.D. degree from McGill University, Canada in 2017, M.Sc. degree from Beijing University of Aeronautics and Astronautics, China in 2013, B.Sc. degree from Harbin Institute of Technology in 2010. Before he coming to Monash, he did one and half year Post-Doc research at Singapore University of Technology and Design and was working on the next generation of CAD software for AM. He is a leading developer of an open-source lattice structure design and optimization software called INTRALATTICE PRO which has been downloaded more than ten thousand times by now.

Tam C. Nguyen

Associate Professor and Deputy Director of Research at St Vincent’s Hospital Melbourne

Associate Professor Tam Nguyen has over 20 years of working in the healthcare, health & medical research environment including tertiary teaching hospitals and research institute across Australia.

Tam is the Deputy Director of Research at St Vincent’s Hospital Melbourne, one of the largest tertiary teaching and research hospitals in Melbourne – responsible for the organisation’s research strategy, research ethics and governance, clinical trials, research innovation and development.

Tam serves as non-executive director and advises several medtech and health tech start-ups on clinical and commercialisation strategy. He is a regular invited speaker on a broad range of topics at national and international conferences. He holds academic appointment with Melbourne University’s Medical School and Monash University’s Medical School – two of the world top 30 (and APAC top 5) medical schools.



3DHEALS2020 Summit Recordings (Premium)


3DHEALS2020 (June 5th-6th, 2020 )was the largest virtual summit this year, in the space of healthcare 3D printing/bioprinting, or elsewhere. This incredible virtual two-day summit gathered more than 70 world experts, 22sessions. It is one of the most well-curated events that engage the audience to learn, think, and re-invent future healthcare.

We believe the recordings of this summit not long serve as a record of technological advanced in time and space, but also a good starting point for anyone who is interested in working and investing in this unique space.

Download Agenda here:

3D Printing Ti6Al4V Orthopaedic Implants: As Easy as Counting 1-2-3 (Video)

Media Coverage:

3DHEALS2020: Thank You!

Adventure for Life: Why You Really Should “Attend” 3DHEALS2020 Live

3DHEALS 2020 Virtual Medical Summit: 3D-Printed Materials in Healthcare (

Reimagining Healthcare With 3D Printing (SME)

3DHEALS 2020 Virtual Medical Summit: Comprehensive Look at Craniomaxillofacial 3D Printing (

3DHEALS2018 Summit Recordings (Premium)

Download 3DHEALS2018 agenda:

The 3DHEALS2018 conference has gathered 45 cross-disciplinary influencers from all over the world to speak on the current and future trends of this burgeoning field, which aims to transform trillion-dollar industries including the manufacturing, medical device, and pharmaceutical industries. The group shares the belief that these technologies will be able to solve many healthcare challenges that existing technologies cannot, including; lowering care costs, increase access to care, and improving care outcomes. 
This two-day activity-filled event includes a Day 1 hands-on workshop to continue the company’s efforts in building and expanding end-user base among medical and dental healthcare providers, but also provide organizations with how-tos to become early adopter and users of 3D printing and bioprinting technologies. Notably, workshops include:

  • Valerie Cooper, also known as the “Denture Queen”, will lead a 1.5 hours hands-on session to teach attendees on how to create dentures with a new digital workflow that can potentially solve the current crisis where there is a lack of affordable denture providers and care.
  • Mayasari Lim from SE3D will also provide a hands-on workshop to teach attendees the basics of bioprinting, a technology that has the potential to solve current organ transplant shortage crisis.
  • Hannah Riedle from FAU Erlange-Nuremberg (Munich, Germany) will provide a 1.5 hour long hands-on workshop to share her digital workflow of generating 3D printed medical anatomical models using open source software. 
  • Erik Birkenederfrom Nixon Peabody LLP will provide an overview on how to protect intellectual properties for the entrepreneurs in this new space.

The attendees are invited to the night reception immediately following the workshops to raise money for two non-profit organizations, Limbforge and the Victoria Hand Project. The special press release for the fundraising event is here.
Day 2 is the main conference day where 40+ industry leaders and innovators will speak. The event’s keynote speaker Mr. Jeffrey Sorenson from Terarecon will start the day with his insights on how an integrated digital system composed of 3D visualization, 3D printing, and artificial intelligence will impact the future of healthcare. Two parallel tracks of expert panel presentations and QA sessions will then ensue.
Among the many topics that will be explored in-depth during the conference, notable ones include:

  • 3D printing in healthcare organizations– Include presentations from multiple institutions with variable resources, including Stanford Healthcare, Children’s Hospital of Phoenix, and Children’s Hospital Boston.
  • Legal and regulatory updates– FDA and CE updates on 3D printed medical devices, IP and liability concerns in healthcare 3D printing and bio-printing innovations. Presenting companies include UL, JNJ, ReedSmith, Nixon Peabody, and Squire Patton Boggs.
  • Digital dentistry– Include current and future trends of implementing 3D printing in dentistry and becoming part of a growing dental in-office digital manufacturing ecosystem.
  • Advanced materials updates– Include current and future material selection of biocompatible polymers and metals for 3D printed medical devices. This powerful panel includes Nag Patibandla from Applied MaterialsRik Jacobs from NextDent (now 3D Systems), Karsten Schlichter from Elkem Silicones, and Ankit Saharan from EOS.
  • Bioprinting panel– includes perspectives of how, and how soon bioprinting will impact the future of organ transplant and pharmaceutical research form a panel of bioprinting startups including Aspect BiosystemsPrellis Biologics, and pharmaceutical startup Viscient Biosciences (partner with Organovo), as well as Medtronics.
  • Orthotics and Prosthetics panel– includes updates from founders of Standard Cyborg, WiDE, the Victoria Hand Project.
  • Orthopedics panel– Includes presentations by UCSF orthopedics and AnatomicsRx, a company that successfully created the first customized sternum implant in the United States.
  • International panel – Includes individual to organizational insights on healthcare 3D printing and bioprinting innovations all over the world.

During lunchtime, the annual global pitch competition will invite 10 startups from healthcare 3D printing, bioprinting, and related 3D visualization technologies such as VR/AR to pitch in front a group of investors including GE Ventures, Asimov Ventures, Digital Industrialist, and other Silicon Valley investors.
The event will conclude with a fireside chat between Dr. Paul D’Urso, CEO of AnatomicsRx, a company that successfully created the first customized sternum implant in the United States, and Penelope Heller, the patient who successfully received the treatment. The presentation aims to provide the audience a real-life example of not only how 3D printing innovation in health care improves patient care, but also the many challenges faced by both the patients and companies to access and implement these innovations.

Media Coverage:

3DHeals 2018 to foster collaboration in medical 3D printing

Nia’s CEO Interviewed For 3DHEALS 2018 Conference

orthopedics sf

San Francisco: 3D Printing and AI in Orthopedics (In-Person, Hybrid) (Premium)

Join us for an exciting in-person event at 555 California Street, San Francisco, CA, USA! Discover the latest advancements in 3D technologies for orthopedics. Learn from industry experts, engage in lively discussions, and network with like-minded professionals. This event is a must-attend for anyone interested in the intersection of 3D printing and orthopedics. Don’t miss out on this opportunity to stay at the forefront of innovation in healthcare. The in-person capacity is only 30 people. Registration closes Feb 9th, 2024 for security reasons!


Craig Rosenblum

Craig Rosenblum is the President of Himed. Over 30 years of operation, Himed has become a global leader in calcium phosphate based biomaterial production and has developed proprietary plasma spray coatings and surface treatments. Craig and his team collaborate directly with dental and medical device manufacturers around the world to provide innovative biomaterial solutions. Craig discovered a unique application for MATRIX MCD® post-processing additively manufactured titanium implantable devices using Himed’s proprietary and biocompatible resorbable blast media. Himed has since formed a strategic partnership with Lithoz, a global market leader in 3D printing, to develop new bioceramic bioinks for medical 3D printing. Craig received his B.S. and M.S. degree in Materials Science & Engineering with a Biomaterials concentration from The Johns Hopkins University (Baltimore, MD). With a focus in biomaterials characterization, his groundbreaking research explored the variations in the microstructure and mechanical properties of dental enamel. These studies were the first to demonstrate the unique heterogeneous nature of enamel. Craig currently serves on The Johns Hopkins University Materials Science & Engineering Advisory Board.

Kerim Genc

Kerim serves as a Product Manager for the Simpleware Group at Synopsys, bringing over a decade of expertise to the role. Joining Simpleware in 2011 to oversee regional sales, he seamlessly navigated through progressively influential positions, including global sales and business development, culminating in his current role as a Product Manager. A highly qualified professional, Kerim earned his BS and MS in biomechanics from the University of Calgary and the Pennsylvania State University, respectively. He further solidified his academic credentials with a Ph.D. in Biomedical Engineering from Case Western Reserve University, where he utilized computational methods to investigate innovative countermeasures addressing spaceflight-induced bone loss and fracture risk.

Alyssa Huffman

Alyssa Huffman is the inventor, founder, and CEO of Allumin8. A company dedicated to bringing research-backed innovation to 3D printed orthopedic and spine hardware in an effort to increase implant survivorship and reduce the likelihood of catastrophic revisions. Allumin8’s implants (including the A8 Integr8 Porous Pedicle Screw System – not cleared for sale in the US) are designed to match the trabecular pattern of bone with the intent to study a variety of biologic therapeutics delivered through or drawn into the hardware. No change in surgical technique. No change in care. No change in pricing. Simply providing options that never before existed in hardware for the betterment of the patient. Licensing opportunities are available by contacting

Dean Hughes

dean hughes

Dean Hughes is the Regional Technical Director at Smith and Nephew Orthopedics. He earned his Bachelor’s and Master’s in Mechanical Engineering from the University of Memphis and an MBA from Christian Brothers University. Dean is a registered professional engineer in the State of Tennessee. Dean has designed, developed, and launched over 50 orthopedic implants and instruments projects with Smith and Nephew over the last 22 years. He also holds 15 US patents and several patents that are pending. Dean resides in Memphis with his wife Linda and enjoys restoring classic cars in his ‘spare’ time.


Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.